Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dhalla
Adil Dhalla, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080265176 | COMPOSITION, METHOD OF AUTHENTICATING, METHODS OF MAKING AUTHENTICATABLE COMPOSITIONS, AUTHENTICATABLE ARTICLES MADE THERE FROM - A composition comprising compound of formula I, a process for preparing the composition comprising compound of formula I, methods of authentication for an article comprising compound of formula I or compound of formula II, authentication technology for polymer based articles comprising compound of formula I or formula II, methods of facilitating such authentication and method of making articles capable of authentication. | 10-30-2008 |
Adil Minoo Dhalla, Dadar Mumbai Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20110065843 | FLUORESCENT BRIGHTENERS, METHODS OF PREPARATION THEREOF, FLUORESCENT BRIGHTENER COMPOSITIONS, AND METHODS OF PREPARATION AND USES THEREOF - A compound of Formula (I) | 03-17-2011 |
Adil Minoo Dhalla, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20100258745 | OPTICAL ARTICLE HAVING ANTI-THEFT FEATURE AND A SYSTEM AND METHOD FOR INHIBITING THEFT OF SAME - A system for altering a functionality of an optical article from a pre-activated state to an activated state, comprising an optical article comprising an optical data layer for storing data, an external radiation source for generating an external stimulus adapted to interact with the optical article, such interaction causing a change in optical accessibility of optically stored data, a directing material, wherein said directing material is for directing the external stimulus to selective portions of the optical article, thereby altering the functionality of the optical article from a pre-activated state to an activated state; a convertible element capable of responding to the external stimulus to irreversibly alter the optical article from the pre-activated state of functionality to the activated state of functionality, wherein said convertible element comprises a color-shift dye, a magnetic material, a thermo-chromic material, a magneto-optical material, a light scattering material, a phase-change material, dye aggregates, or combinations thereof. | 10-14-2010 |
Adil Minoo Dhalla, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20110196075 | AUTHENTICATABLE ARTICLES AND METHODS THEREFOR - An article comprising the compound of Formula (I): | 08-11-2011 |
Arvinder Dhalla, Mountain View, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080255031 | METHOD FOR ENHANCING INSULIN SECRETION - The invention is directed to methods for enhancing endogenous insulin levels in a patient in need thereof which method comprises administering to the patient an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine. It is also directed to methods of treatment comprising racemic ranolazine or the R- or S-enantiomer of ranolazine for enhancing endogenous insulin levels in a patient in need thereof. It is also directed to a composition comprising an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine and at least one anti-diabetic agent. | 10-16-2008 |
| 20090118221 | METHOD OF TREATING ARRHYTHMIAS - Methods are provided for treating arrhythmia in a manner that minimizes undesirable side effects, comprising administration of a therapeutically effective minimal dose of an A | 05-07-2009 |
| 20090203689 | ABCA-1 ELEVATING COMPOUNDS AND METHODS - Disclosed are novel compounds of Formula I | 08-13-2009 |
| 20090247557 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS - Disclosed are novel compounds a compound of Formula I | 10-01-2009 |
| 20100105695 | METHOD FOR ENHANCING INSULIN SECRETION - The invention is directed to methods for enhancing endogenous insulin levels in a patient in need thereof which method comprises administering to the patient an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine. It is also directed to methods of treatment comprising racemic ranolazine or the R- or S-enantiomer of ranolazine for enhancing endogenous insulin levels in a patient in need thereof. It is also directed to a composition comprising an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine and at least one anti-diabetic agent. | 04-29-2010 |
| 20100210579 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS - Disclosed are novel compounds a compound of Formula I | 08-19-2010 |